Latest News and Press Releases
Want to stay updated on the latest news?
-
Angelini Ventures marks its first portfolio exit as ResMed acquires Noctrix Health, validating its strategy of backing breakthrough healthcare innovation.
-
ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at...
-
CARMEL, Ind., May 12, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...
-
Discure Technologies appoints Dr. Ray Baker to its Board of Directors, and fractional Chief Medical Officer, supporting the company onto its next stage.
-
ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in...
-
CARMEL, Ind., April 22, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for...
-
Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a medical technology company advancing non-invasive neuromodulation for people living with spinal cord injury, today announced U.S. Food...
-
“We are pleased to welcome Don Payerle to our Board of Managers,” said Aure Bruneau, Chief Executive Officer of Curonix.
-
Los Angeles, CA, March 05, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a medical technology company advancing non-invasive neuromodulation for people living with spinal cord injury, today announced the closing...
-
SAN FRANCISCO, March 04, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that the Company’s pivotal...